The Highest Standard in Peptide Research.

Bodytide Wellness Lab
HORMONE OPTIMISATION & VITALITY

IPAMORELIN 15MG

Selective muscle growth and fat loss support

Ipamorelin is a pentapeptide ghrelin receptor agonist engineered to stimulate clean, pulsatile growth hormone release without elevating cortisol or prolactin.

IPAMORELIN 15MG
£114.00

Active Ingredient: 15.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Current batch fully reserved. Next allocation underway.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Lean Muscle Support: Promotes nitrogen retention and muscle tissue preservation.
Visceral Fat Clearance: Accelerates fatty acid oxidation, targeting abdominal fat reserves.
Bone Density Support: Stimulates osteoblast activity to maintain bone mineral density.
Clean Endocrine Profile: Operates without raising cortisol, prolactin, or aldosterone levels.
Selective GH Pulse Stimulation: Triggers clean growth hormone pulses from the anterior pituitary gland.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is IPAMORELIN 15MG?

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike older peptides in its class, Ipamorelin mimics natural pulsatile growth hormone release without stimulating appetite or raising stress hormones like cortisol and prolactin.

The Cellular Mechanism

GHS-R1a Receptor Binding: Binds selectively to growth hormone secretagogue receptors on pituitary somatotropes.
Pulsatile GH Amplification: Triggers intracellular calcium influx to stimulate natural growth hormone release.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 250mcg to 500mcg daily, administered in the morning. To allow cellular receptors to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1-2 (Baseline Priming): An initial daily dose of 250mcg in the morning (5 clicks once per day).

Weeks 2 Onwards (Active Titration): The protocol scales to 500mcg daily in the morning (10 clicks once per day).

Once targets are achieved, dosage can be reviewed and adjusted according to results.

Possible Side Effects

Transient Flushing: Mild, brief facial warming immediately following injection.
Minor Head Sensation: Slight, temporary head rush or light-headedness resolving within minutes.